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Abstract Trypsin-like serine proteases are essential in physiological processes. Studies have
shown that N-glycans are important for serine protease expression and secretion, but the
underlying mechanisms are poorly understood. Here, we report a common mechanism of
N-glycosylation in the protease domains of corin, enteropeptidase and prothrombin in calnexin-
mediated glycoprotein folding and extracellular expression. This mechanism, which is independent
of calreticulin and operates in a domain-autonomous manner, involves two steps: direct calnexin
binding to target proteins and subsequent calnexin binding to monoglucosylated N-glycans.
Elimination of N-glycosylation sites in the protease domains of corin, enteropeptidase and
prothrombin inhibits corin and enteropeptidase cell surface expression and prothrombin secretion
in transfected HEK293 cells. Similarly, knocking down calnexin expression in cultured
cardiomyocytes and hepatocytes reduced corin cell surface expression and prothrombin secretion,
respectively. Our results suggest that this may be a general mechanism in the trypsin-like serine
proteases with N-glycosylation sites in their protease domains.
DOI: https://doi.org/10.7554/eLife.35672.001
Introduction
In the human genome, ~2% of the genes encode proteases, among which trypsin-like serine pro-
teases are a major group (Overall and Blobel, 2007). Most of the trypsin-like serine proteases act
extracellularly to participate in physiological processes, including embryonic development, food
digestion, blood coagulation and hormone processing (Lo´pez-Otı´n and Hunter, 2010; Neu-
rath, 1984; Overall and Blobel, 2007; Perona and Craik, 1995; Stroud, 1974). Dysregulated serine
protease expression and activity contribute to major health problems such as cardiovascular disease,
cancer metastasis, inflammation, and neurological disease (Craik et al., 2011; Gohara and Di Cera,
2011).
N-glycosylation is a common post-translational modification in proteins (Eklund and Freeze,
2005; Patterson, 2005; Varki, 1993). About two thirds of the predicted human proteins contain
N-glycosylation sites (Apweiler et al., 1999). Consistently, most of the trypsin superfamily members
are N-glycosylated proteins (Bolt et al., 2007; Jiang et al., 2014; Liao et al., 2007; Miyake et al.,
2010; Wu and Suttie, 1999). Many N-glycosylation sites in these serine proteases, especially those
in the protease domain, are highly conserved; that is, a specific N-glycosylation site in a protease is
conserved not only in the homologs of different species, but also at the same location in other
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members of the protease superfamily. Such conservation indicates the functional importance.
Indeed, N-glycosylation has been shown to regulate the extracellular expression, secretion and acti-
vation of trypsin-like serine proteases, although the underlying mechanisms are not elucidated
(Bolt et al., 2007; Gladysheva et al., 2008; Jiang et al., 2014; Lai et al., 2015; Liao et al., 2007;
Miyake et al., 2010; Wu and Suttie, 1999). It is unclear if N-glycans at the conserved sites have a
general role in the biosynthesis of the trypsin-like serine proteases.
Corin is a trypsin-like serine protease that activates natriuretic peptides (Cui et al., 2012;
Li et al., 2017; Yan et al., 2000). It consists of a cytoplasmic tail, a transmembrane domain and an
extracellular region with multiple protein modules and a C-terminal protease domain (Hooper et al.,
2000; Yan et al., 1999). In cells, corin is made as a zymogen and activated on the cell surface by
proprotein convertase subtilisin/kexin-6 (PCSK6) (Chen et al., 2015; 2018). CORIN and PCSK6 var-
iants that impair corin cell surface expression and zymogen activation have been identified in
patients with hypertensive diseases (Chen et al., 2015; Cui et al., 2012; Dong et al., 2013;
2014; Dries et al., 2005; Zhang et al., 2014; 2017).
Human corin has 19 N-glycosylation sites in its extracellular region (Yan et al., 1999). We and
others have shown that N-glycosylation is critical for corin cell surface expression and zymogen acti-
vation (Gladysheva et al., 2008; Liao et al., 2007; Wang et al., 2015). Abolishing N-glycosylation
sites at Asn80 and Asn231 in the pro-peptide region increased corin shedding on the cell surface,
whereas abolishing N-glycosylation site at Asn1022 (N1022), the only N-glycosylation site in the pro-
tease domain of human corin, reduced the cell surface expression (Wang et al., 2015). To date, how
N-glycosylation at N1022 regulates corin cell surface expression remains unknown.
In this study, we made membrane-bound and soluble forms of corin with or without the N1022
N-glycosylation site and analyzed the mutant proteins in transfected cells. We also did proteomic
analysis to identify intracellular proteins interacting with corin. We verified our findings in enteropep-
tidase (also called enterokinase, EK), a transmembrane serine protease, and prothrombin, a secreted
serine protease. We found that N-glycosylation in the protease domain of corin, EK and prothrombin
has a common role in regulating the extracellular expression of these proteases, which involves cal-
nexin-assisted protein folding and ER exiting.
Results
Glycosylation at N1022 promotes cell surface expression of corin
zymogen
N1022 is a conserved glycosylation site in the corin protease domain (Figure 1A, Figure 1—figure
supplement 1 and Figure 1—figure supplement 2). Abolishing this site impairs corin cell surface
expression and zymogen activation (Wang et al., 2015). To test if the effect is related to zymogen
activation, we analyzed corin mutants lacking the activation site (R801A) with or without the N1022
glycosylation site (Figure 1A). In western blotting of transfected cell lysates, levels of corin zymogen
bands (~160–200 kDa) were similar in corin WT and mutants N1022Q, R801A, and R801A/N1022Q
(Figure 1B, left). In corin WT, the cleaved protease domain fragment (Corin-p) migrated as an ~40
kDa band under reducing conditions. In the N1022Q mutant, the Corin-p band was lighter and
migrated faster, due to the lack of N1022 glycosylation and poor zymogen activation (Wang et al.,
2015). As expected, no Corin-p band was detected in mutants R801A and R801/N1022Q lacking
the activation site. In biotin-labeled cell surface proteins (Figure 1B, right), levels of corin bands in
the N1022Q mutant were 43 ± 9% of that in WT (p=0.002) and levels in the R801A/N1022Q mutant
were 41 ± 8% of that in R801A (p=0.027). The total intensity of WT bands (Corin and Corin-p) was
similar to that of R801A (Corin band only). The results indicate that lacking N1022 glycosylation
reduces corin cell surface expression with or without the activation cleavage at R801.
Glycosylation at N1022 promotes soluble corin secretion
The cytoplasmic tail was shown to regulate corin intracellular trafficking (Li et al., 2015; Qi et al.,
2011; Zhang et al., 2014). To test if the cytoplasmic and the transmembrane domains are necessary
for the N-glycan-mediated corin expression, we tested soluble corin mutants with the Igk signal pep-
tide with or without mutations at R801 and N1022 (Figure 1C). In western blotting of transfected
cell lysates, sWT and the mutants sN1022Q, sR801A and sR801A/N1022Q appeared as single bands
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at similar levels (Figure 1D, left). In the medium (Figure 1D, right), levels of sWT and sR801A were
similar, whereas levels of sN1022Q and sR801A/N1022Q were 11 ± 2 and 9 ± 4% of sWT and
sR801A, respectively, indicating that glycosylation at N1022 promotes soluble corin secretion.
Figure 1. N-glycosylation at N1022 in single-chain and soluble corin. (A) Illustration of human corin WT and mutants with or without R801 activation site
and N1022 N-glycosylation site. TM: transmembrane; Fz: frizzled; LDLR: LDL receptor; SR: scavenger receptor. An arrow indicates the PCSK6-mediated
activation cleavage site at Arg801 (R801). A disulfide bond linking the pro-peptide region and the protease domain is indicated by a dashed line. (B)
Western blotting, under reducing conditions, of corin proteins in lysates (left) or on the cell surface (right) from HEK293 cells. Corin zymogen bands
(Corin) and the cleaved protease domain fragment (Corin-p) are indicated. Levels of GAPDH in cell lysates and a Coomassie Blue (CB)-stained non-
specific protein in biotin-labeled cell surface proteins were used to assess amounts of proteins in each sample. Relative corin levels on the cell surface
are estimated by densitometric analysis of western blots. Data are means ± S.E. from four independent experiments. p-Values are shown in the bar
graph. (C) Illustration of soluble corin (sWT) and mutants, in which the cytoplasmic and transmembrane domains were replaced by the Igk signal
peptide (SP). (D) Western blotting of soluble corin in lysates (left) and medium (right) from HEK293 cells. Levels of GAPDH in cell lysates and a
Coomassie Blue (CB)-stained non-specific protein in the conditioned media were used to assess amounts of proteins in each sample. Relative levels of
the secreted corin in the medium were estimated by densitometric analysis of Western blots. Data are means ± S.E. from three independent
experiments. p-Values are shown in the bar graph.
DOI: https://doi.org/10.7554/eLife.35672.002
The following figure supplements are available for figure 1:
Figure supplement 1. The phylogenetic tree of corin proteins in different species.
DOI: https://doi.org/10.7554/eLife.35672.003
Figure supplement 2. Alignments of the protease domain of trypsin-like serine proteases.
DOI: https://doi.org/10.7554/eLife.35672.004
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Glycosylation at N1022 promotes corin exiting from the ER
In Western blotting of lysates from cycloheximide (CHX)-treated cells, levels of WT and the N1022Q
mutant decreased over time (Figure 2A,B). After 8 hr of CHX treatment, the levels were 7 ± 2% for
WT and 32 ± 3% for N1022Q with calculated half-lives of 3.8 ± 0.4 and 6.1 ± 0.3 hr, respectively
(p=0.003), indicating that abolishing N1022 glycosylation did not reduce corin protein stability but
impaired intracellular trafficking. We digested the proteins with glycosidase Endo H, which removes
high-mannose and hybrid N-glycans on proteins in the ER or early Golgi. On western blots, the ratio
of Endo H-sensitive vs. resistant corin bands was higher in the N1022Q mutant than WT after CHX
treatment for 4 hr (Figure 2C), indicating that the N1022Q mutant was retained in the ER or early
Golgi.
We then co-stained corin and protein disulfide isomerase (PDI) in the cells. Without CHX treat-
ment, WT or N1022Q corin and PDI staining mostly overlapped (Figure 3A) with similar Pearson’s
correlation coefficients (0.49 ± 0.04 and 0.48 ± 0.06, respectively) (Figure 3B). After CHX treatment
for 4 hr, there was little corin staining in the WT corin-expressing cells, whereas corin staining was
strong in the N1022Q-expressing cells (Figure 3A, corin (red) vs. PDI (green) ratio in two bottom
right panels) with Pearson’s correlation coefficients of 0.15 ± 0.06 and 0.35 ± 0.05, respectively
(p=0.020) (Figure 3B). In co-staining studies for corin and TGN46, a Golgi marker, WT and N1022Q
corin had similar distribution patterns with or without CHX treatment (Figure 3C,D). These results
are consistent with findings from the Endo H experiment, indicating that abolishing N1022 glycosyla-
tion prevents corin from exiting the ER.
Increased N1022Q binding to calnexin and BiP
To identify proteins that interact differentially with corin WT and the N1022Q mutant, we treated
the cells with dithiobis succinimidyl propionate (DSP), a protein cross-linker, and did proteomic anal-
ysis in samples co-immunoprecipitated with corin. A total of 387 proteins were detected
(Supplementary file 1). Among the proteins with 2 fold differences between WT and N1022Q
were calnexin and BiP (binding immunoglobulin protein) (Supplementary file 2), two ER proteins in
glycoprotein folding and quality control (Hebert et al., 1995; Helenius and Aebi, 2001). Calnexin
and BiP levels were 2.1- and 2.0-fold higher, respectively, in N1022Q-derived samples than those in
WT (Supplementary file 2). In contrast, the ratio for calreticulin, another ER chaperone in glycopro-
tein folding (Hebert et al., 1995; Helenius and Aebi, 2001), was 0.88-fold, whereas the ratios for
PDI family members A3 and A4 were 1.24- and 1.67-fold, respectively (Supplementary file 1).
To show direct interactions between corin and calnexin or BiP, we immunoprecipitated corin in
WT- and N1022Q-expressing cells and analyzed co-precipitated proteins by western blotting. Cal-
nexin and BiP levels from N1022Q-expressing cells were 137 ± 9 and 562 ± 82%, respectively, of
those from WT (Figure 4A–C). In contrast, levels of calreticulin, HSP70 and HSP90 (two ER chaper-
ones), and PDI were all similar between WT and N1022Q (Figure 4A,D). In controls, similar levels
between WT and N1022Q were found in V5 pull-down samples and total cell lysates (Figure 4A).
These results indicate that abolishing N1022 glycosylation increases direct corin binding to calnexin
and BiP.
Effects of glucosidase inhibition on corin binding to calnexin and BiP
In calnexin-assisted glycoprotein folding (Caramelo and Parodi, 2008; Helenius and Aebi, 2001),
triglucosylated oligosaccharides on nascent proteins are trimmed by a-glucosidases I and II to mono-
glucosylated oligosaccharides, allowing calnexin binding to N-glycans to assist protein folding
(Figure 5A). Calnexin may bind directly to target proteins via protein-protein interactions, but the
functional significance is unclear (Helenius and Aebi, 2001; Ihara et al., 1999). BiP retains poorly
folded proteins in the ER (Figure 5A). We treated the cells expressing WT corin and N1022Q with 1-
deoxynojirimycin (DNJ), which inhibits glucosidase I and II (Saunier et al., 1982) (Figure 5A). With-
out DNJ treatment, calnexin and BiP levels in N1022Q-derived samples were 131 ± 7 and 473 ±
19%, respectively, of WT (Figure 5B–D). With DNJ treatment, calnexin and BiP levels increased and
became similar between the cells expressing WT and the N1022Q mutant (Figure 5B–D), indicating
that inhibiting glucosidase activities blocked calnexin binding to N-glycans at N1022 and other
N-glycosylation sites on corin and impaired calnexin-assisted folding, resulting in increased direct
corin binding to calnexin and BiP.
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Figure 2. Analysis of intracellular corin by CHX-based protein chase and Endo H digestion. (A) Western blotting of
corin in HEK293 cells treated without (0) or with CHX over time (h). (B) Percentages of corin WT and the mutant
N1022Q levels, with corresponding levels at 0 hr being 100%, were estimated by densitometric analysis of Western
blots. In addition to corin zymogen bands (Corin), a weak Corin-p band was detected, which likely represented
activated corin on the cell surface. Data are means ± S.E. from four independent experiments. P values vs. WT at
the same time point are shown. n.s.: not significant. The half-lives in h for WT (blue) and N1022Q (red) are
indicated. (C) Endo H digestion of proteins from HEK293 cells without (0) or with CHX treatment for 4 hr. Corin
proteins without (-) or with (+) Endo H digestion were analyzed by western blotting. Endo H-sensitive and resistant
bands are indicated.
DOI: https://doi.org/10.7554/eLife.35672.005
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Effect of N-glycosylation on cell surface expression of chimeric proteins
We next made a chimeric protein (CorinEK4N), in which the corin protease domain was replaced by
the EK protease domain with four N-glycosylation sites (Figure 6A), and additional mutants without
the four glycosylation sites (CorinEK4Q) and with (CorinEK4Q/N) a new glycosylation site corre-
sponding to N1022 in corin (Figure 6A). On Western blots, CorinEK4N had two major bands (~190
and~220 kDa) (Figure 6B). The ~220 kDa band (open arrowhead) was on the cell surface and remov-
able by trypsin before the cells were lysed, whereas the ~190 kDa band (top black arrowhead) was
intracellular and resistant to trypsin. In CorinEK4Q, levels of the cell surface protein were 31 ± 5% of
CorinEK4N (Figure 6B). In CorinEK4Q/N, the level was lower than that in CorinEK4N (49 ± 8%), but
higher than that in CorinEK4Q (Figure 6B). To exclude the possibility that low levels of the cell sur-
face chimeric proteins were due to increased shedding, we examined the shed proteins in the
medium. Levels of CorinEK4Q and CorinEK4Q/N were 8 ± 1 and 29 ± 4%, respectively, of that in
CorinEK4N (Figure 6C). These results indicate that the function of N-glycans in the protease domain
in promoting cell surface expression is not unique to corin.
N-glycosylation in EK and prothrombin protease domains
We next studied EK (Kitamoto et al., 1994), a transmembrane serine protease, and prothrombin
(Wu et al., 1991), a secreted serine protease. We made EK mutant (EK-4Q) and prothrombin mutant
(PT-N416Q) without N-glycosylation sites in the protease domains (Figure 7A,B). On western blots
(Figure 7C,D), EK-4Q and PT-N416Q bands migrated faster than those in EK-WT and PT-WT. Levels
of trypsin-removable EK-4Q band on the cell surface, which migrated much closer to the intracellular
band due to the loss of 4 N-glycosylation sites, were 14 ± 1% of EK-WT (Figure 7C). Levels of PT-
WT and PT-N416Q in cell lysates were similar, but the level of PT-N416Q in the medium was 56 ±
30% of PT-WT (Figure 7D). These results indicate that N-glycans in the protease domain are impor-
tant for EK cell surface expression or prothrombin secretion.
Figure 3. Intracellular distribution of corin WT and the N1022Q mutant. (A) Co-staining of corin and PDI in HEK293 cells expressing WT corin and the
N1022Q mutant without (0) or with CHX treatment for 4 hr. (B) Correlation of red (corin) and green (PDI) colors within individual cells was analyzed by
Pearson’s correlation coefficient. p-Value is shown. n.s.: not significant. (C) Co-staining of corin and TGN46 (green) in HEK293 cells expressing WT corin
and the N1022 mutant without (0) or with CHX treatment for 4 hr. (D) Correlation of red (corin) and TGN46 (green) colors within individual cells was
analyzed by Pearson’s correlation coefficient. Data are means ± S.E. from five independent experiments.
DOI: https://doi.org/10.7554/eLife.35672.006
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N-glycans in EK and prothrombin protease domains interact with
calnexin and BiP
In co-immunoprecipitation and western blotting, calnexin levels in EK-4Q- and PT-N416Q-expressing
cells were 165 ± 12 and 171 ± 8%, respectively, of those in respective WT controls (Figure 8A,B).
BiP levels were also higher in EK-4Q- and PT-N416Q-expressing cells (Figure 8A,B). In contrast, cal-
reticulin levels were similar in EK-4Q and PT-N416Q compared with corresponding WT controls. In
other controls, EK and PT levels in V5 pull-down samples were similar between the WTs and mutants
(Figure 8A,B). In DNJ inhibition studies (Figure 8C,D), calnexin and BiP levels increased in all sam-
ples. There were no significant differences in calnexin and BiP levels between the DNJ-treated cells
expressing ET-WT and EK-4Q or PT-WT and PT-N416Q. These results indicate a general function of
N-glycans in the protease domain in trypsin-like proteases in calnexin-assisted protein folding.
Effects of DNJ treatment and calnexin knockdown in cardiomyocytes
and hepatocytes
We verified our findings in murine HL-1 cardiomyocytes and human HepG2 hepatocytes expressing
endogenous corin and prothrombin, respectively. In DNJ-treated HL-1 cells, cell surface corin levels
were 26 ± 10% of untreated controls, as estimated by western blotting and densitometry
(Figure 9A). In DNJ-treated HepG2 cells, prothrombin levels in lysates were similar to untreated
Figure 4. Interactions between corin and ER chaperones. (A) Corin proteins in HEK293 cells expressing WT corin and the N1022Q mutant were
immunoprecipitated (IP) with an anti-V5 antibody that recognizes the C-terminal V5 tag in corin. Chaperones that co-precipitated with corin were
analyzed by immunoblotting (IB, top six panels). Corin in V5 pull-down samples was verified. Corin and GAPDH in the cell lysates were analyzed as
additional controls (bottom two panels). Relative levels of calnexin (B), BiP (C), calreticulin, HSP70, HSP90 and PDI (D) were estimated by densitometric
analysis of western blots. Data are means ± S.E. from three independent experiments. p-Values are shown in bar graphs. n.s.: not significant.
DOI: https://doi.org/10.7554/eLife.35672.007
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controls, whereas the level in the conditioned medium was ~53% of untreated control medium, as
measured by ELISA (Figure 9B). We next knocked down calnexin expression in HL-1 and HepG2
cells using siRNAs targeting murine and human calnexin genes, respectively. Reduced calnexin pro-
tein levels in those cells were verified by western blotting (Figure 9C,D). Western blotting and ELISA
analyses showed reduced levels of cell surface corin and prothrombin in the conditioned medium,
respectively, in HL-1 and HepG2 cells, in which calnexin expression was knocked down (Figure 9C,
D).
Discussion
N-glycosylation is important in protein expression and function (Dalziel et al., 2014; Hart and Cope-
land, 2010; Moremen et al., 2012). Previously, N-glycosylation at N1022 was found to be critical
Figure 5. Analysis of calnexin interaction. (A) A model of calnexin-assisted glycoprotein folding. Cal: calnexin; blue dots: glucose residues. DNJ inhibits
glucosidases I and II. (B) Co-immunoprecipitation (IP) and western blotting (IB) of corin associated calnexin and BiP in HEK293 cells expressing WT corin
or the N1022Q mutant without (-) or with (+) DNJ treatment (top two panels). Corin in V5 pull-down samples was verified (third panel). Corin and
GAPDH in the lysates were also verified (bottom two panels). Relative calnexin (C) and BiP (D) levels were estimated by densitometric analysis of
western blots. Data are means ± S.E. from three independent experiments. p-Values are shown in bar graphs. n.s.: not significant.
DOI: https://doi.org/10.7554/eLife.35672.008
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for corin cell surface expression, but the underlying mechanism was unknown (Wang et al., 2015). In
this study, we found that N-glycosylation at this site was important for corin folding and trafficking in
the ER. In proteomic analysis, we identified calnexin and BiP, two ER proteins that bound preferably
to the N1022Q mutant.
Calnexin acts in glycoprotein folding (Caramelo and Parodi, 2008; Helenius and Aebi, 2001).
Unlike in heat-shock chaperone-mediated protein folding, which involves direct protein-protein bind-
ing, calnexin binds to monoglucosylated oligosaccharides on glycoproteins after triglucosylated
N-glycans are trimmed by glucosidases I and II. Calnexin also binds to target proteins via direct
hydrophobic interactions (Brockmeier and Williams, 2006). Such interactions alone, however, are
insufficient for glycoprotein folding. We found increased binding of the N1022Q mutant to calnexin
and BiP, indicating that N-glycans at N1022 on corin is important for calnexin-assisted protein fold-
ing and ER exiting. The results led to a working model, in which calnexin first binds to nascent corin
through direct protein-protein interactions. Subsequent binding of calnexin to monoglucosylated
Figure 6. Analysis of N-glycosylation in the protease domain of corin-EK chimeras. (A) In CorinEK4N, the corin protease domain (Corin-P) was replaced
by the EK protease domain (EK-P). The ADAM10-mediated shedding site is indicated by an arrowhead. In CorinEK4Q, all four N-glycosylation sites in
the EK protease domain were mutated by Gln (Q) residues. In CorinEK4Q/N, a new N-glycosylation site corresponding to N1022 in corin was added to
CorinEK4Q. (B) Western blotting of CorinEK4N, CorinEK4Q and CorinEK4Q/N in transfected cells treated without (-) or with (+) trypsin before the cells
were lysed. GAPDH levels in cell lysates were used to assess amounts of proteins in each sample. (C) Western blotting of shed corin fragments the in
medium. Corin levels on the cell surface (B) and in the medium (C) were estimated by densitometric analysis of western blots. In (C), levels of a
Coomassie Blue (CB)-stained non-specific protein were used to assess amounts of proteins in each sample. Data are means ± S.E. from at least three
independent experiments. p-Values are shown in bar graphs.
DOI: https://doi.org/10.7554/eLife.35672.009
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N-glycans on corin, at N1022 and other N-glycosylation sites, facilitates corin folding. The resultant
conformational change in corin disrupts the interaction with calnexin, allowing corin to exit the ER.
Consistent with this model, we showed that the treatment of DNJ, a glucosidase inhibitor, increased
the binding of the N1022Q mutant and WT corin to calnexin and BiP to similar levels. The results
support the importance of N-glycan-calnexin interactions in corin folding and ER exiting. Moreover,
the results indicate that N-glycans at other N-glycosylation sites on corin are also involved in the cal-
nexin interaction.
Human corin contains 19 N-glycosylation sites (Wang et al., 2015; Yan et al., 1999). Among
them, N1022 is the only site in the protease domain. Our findings indicate that N-glycosylation in
the protease domain is critical for calnexin-assisted folding. In trypsin-like serine proteases, N-glyco-
sylation sites in the protease domain are common. Previously, N-glycosylation in the protease
domain of factor VII (FVII) was shown to promote FVII secretion in COS-7 and CHO cells (Bolt et al.,
2007). Abolishing the N-glycosylation site in the protease domain of chymotrypsin C reduced the
secretion in HEK293 cells (Bence and Sahin-To´th, 2011). Conversely, overexpression of a mutant
chymotrypsin C lacking the N-glycosylation in the protease domain caused ER stress in cancer cells
Figure 7. Analysis of N-glycosylation sites in the protease domain of EK and prothrombin. (A) Illustration of EK WT and the mutant lacking the
indicated N-glycosylation sites (EK-4Q). EK domains include transmembrane (TM), SEA, LDLR, CUB, MAM, scavenger receptor (SR) and protease
domains. (B) Illustration of prothrombin WT and the PT-N416Q mutant lacking the N-glycosylation site in the protease domain. Prothrombin domains
include signal peptide (SP), Gla (GLA), kringle (KR) and protease domains. (C) Western blotting of EK-WT and EK-4Q in HEK293 cells without (-) or with
(+) trypsin treatment before the cells were lysed. The cell surface (trypsin-sensitive; white dots) and intracellular (trypsin-resistant; black dots) bands are
indicated. Relative levels of surface EK bands in EK-WT and EK-4Q were estimated by densitometric analysis of western blots. Data are means ± S.E.
from four independent experiments. p-Value is shown. (D) Western blotting of PT-WT and PT-N416Q in cell lysates (left) and the medium (right) from
HEK293 cells. Relative levels of PT-WT and PT-N416Q in the medium were estimated by densitometric analysis of western blots. Levels of GAPDH in
cell lysates and a Coomassie Blue (CB)-stained non-specific protein in the conditioned medium were used to assess protein amounts in each sample.
Data are means ± S.E. from four independent experiments. p-Value is shown.
DOI: https://doi.org/10.7554/eLife.35672.010
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(Bence and Sahin-To´th, 2011). These data suggest that N-glycosylation in the protease domain of
trypsin-like serine proteases has a general role in calnexin binding and protein folding. Consistent
with this hypothesis, DNJ treatment and calnexin knockdown decreased corin cell surface expression
and prothrombin secretion in cardiomyocytes and hepatocytes, respectively. Moreover, elimination
of N-glycosylation sites in the protease domain of EK or prothrombin increased EK and prothrombin
binding to calnexin and BiP and decreased EK cell surface expression or prothrombin secretion in
HEK293 cells. These results show that in corin, EK and prothrombin, which have distinct protein
domain structures and physiological functions, N-glycosylation in their protease domains has a com-
mon function in calnexin-assisted folding and extracellular expression. Possibly, this is a general
Figure 8. Interactions of EK and prothrombin with chaperones. Co-immunoprecipitation (IP) and Western blotting (IB) of EK-WT and EK-4Q (A) or PT-
WT and PT-N416Q (B) binding to calnexin, BiP and calreticulin (top three panels). EK (A) and PT (B) proteins in V5 pull-down samples were verified. EK,
PT and GAPDH in cell lysates were also verified by western blotting (bottom two panels). Relative levels of calnexin, BiP and calreticulin associated with
EK-WT and EK-4Q (A) or PT-WT and PT-N416Q (B) were estimated by densitometric analysis of Western blots. Data are means ± S.E. from three and
four independent experiments, respectively. p-Values are shown in bar graphs. IP and IB analysis of EK-WT and EK-4Q (C) or PT-WT and PT-N416Q (D)
binding to calnexin and BiP in the cells without (-) or with (+) DNJ treatment (top two panels). EK (A) and PT (B) proteins in V5 pull-down samples were
verified. EK, PT and GAPDH proteins in cell lysates were also verified. Relative calnexin and BiP levels associated with EK-WT and EK-4Q (C) or PT-WT
and PT-N416Q (D) were estimated by densitometric analysis of Western blots. Data are means ± S.E. from three independent experiments. p-Values are
shown in bar graphs.
DOI: https://doi.org/10.7554/eLife.35672.011
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mechanism in most, if not all, trypsin-like serine proteases that have N-glycosylation sites in their
protease domains.
Calreticulin is a soluble calnexin homologous in the ER and acts as a key partner in the calnexin-
calreticulin cycle (Caramelo and Parodi, 2008; Ellgaard and Helenius, 2001; Helenius and Aebi,
2001). Like calnexin, calreticulin binds to monoglucosylated oligosaccharides on glycoproteins. In a
previous study, inhibition of glucosidase II increased calreticulin binding to cruzipain, a protozoan
cysteine protease (Labriola et al., 1999). In our study, we found increased binding of N1022Q corin,
EK-4Q and PT-N416Q mutants to calnexin but not calreticulin, indicating that calnexin is the primary
ER chaperone that interacts with N-glycans in the protease domain of these proteases. If both cal-
nexin and calreticulin recognize similar monoglucosylated N-glycans, how do these proteins distin-
guish their glycoprotein substrates? Unlike calreticulin, calnexin has a transmembrane domain
anchoring calnexin on the ER membrane (Dalziel et al., 2014; Ellgaard and Frickel, 2003). In most
trypsin-like serine proteases, the protease domain is C-terminal. Possibly, the membrane-bound cal-
nexin is more accessible to the N-glycans in the C-terminal protease domain, which comes last from
Figure 9. Effects of DNJ treatment and calnexin knockdown. HL-1 (A) and HepG2 (B) cells were cultured without (-) or with (+) DNJ. Recombinant
human corin expression in transfected HEK293 cells were included as a control (A, left). Corin cell surface expression (A) and prothrombin expression in
cell lysates and secretion in the medium (B) were analyzed by western blotting and ELISA, respectively. Levels of corin cell surface band (open
arrowhead) were estimated by densitometric analysis of western blots. Data are means ± S.E. from four independent experiments. p-Values are shown
in bar graphs. To knockdown calnexin expression, HL-1 (C) and HepG2 (D) cells were transfected with calnexin-targeting or control scrambled siRNAs.
Calnexin expression levels in the transfected cells were verified by western blotting. Corin cell surface expression (C) and prothrombin expression in cell
lysates and secretion in the medium (D) were analyzed by western blotting and ELISA, respectively. Data are means ± S.E. from three independent
experiments. p-Values are shown in bar graphs. n.s.: not significant.
DOI: https://doi.org/10.7554/eLife.35672.012
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the translocon on the ER membrane in protein synthesis. This may explain that despite the 18 N-gly-
cosylation sites in the pro-peptide of corin, N-glycosylation at N1022 in the protease domain is
required for optimal corin folding and ER exiting. Consistently, N-glycosylation in the protease
domain of the CorinEK4N mutant promotes the cell surface expression of the chimeric protein.
These results indicate that N-glycans in the protease domain regulate calnexin-assisted folding in a
domain-autonomous and calreticulin-independent manner.
The importance of N-glycans in glycoprotein folding varies depending on proteins and cell types
(Helenius and Aebi, 2001). In the trypsin-like protease superfamily, not all members are N-glycosy-
lated. Some members have N-glycosylation sites in the pro-peptide but not in the protease domain.
It is attempting to postulate that N-glycosylation in the protease domain offers an advantage in pro-
tein folding efficiency and hence protein production. The requirement of N-glycosylation in a partic-
ular protease may depend on its expression level and specific cell environments. More studies are
needed to test the folding efficiencies between the trypsin-like proteases with and without N-glyco-
sylation sites in their protease domains in different cells. As trypsin-like proteases are used as biolog-
ics to treat human diseases (Craik et al., 2011), creation of new N-glycosylation sites may also be a
strategy to increase the production of recombinant proteases in vitro.
In summary, we identify a common mechanism of N-glycosylation in the protease domains of
corin, EK and prothrombin in calnexin-mediated folding and ER exiting. This process is calreticulin-
independent, operates in a domain-autonomous manner, and involves two steps: direct calnexin
binding to the target protein and subsequent calnexin binding to monoglucosylated N-glycans. Our
findings suggest that this may be a general mechanism in the trypsin-like proteases with N-glycosyla-
tion sites in their protease domains. Naturally-occurring mutations disrupting such N-glycosylation
sites may impair the expression and function of the trypsin-like serine proteases.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Gene (Homo sapiens) Corin NCBI NM_006587.3
Gene (H. sapiens) Prothrombin, PT NCBI NM_002772.2
Gene (H. sapiens) Enteropeptidase, EK NCBI NM_000506.4
Genetic reagent
(H. sapiens)
Calnexin (siRNA kit) Origene SR300576
Genetic reagent
(Mus musculus)
Calnexin (siRNA kit) Origene SR417891
Cell line
(H. sapiens)
HEK293 ATCC CRL-1573 STR profiling, no mycoplasma
contamination
Cell line
(M. musculus)
HL-1 PMID: 21518754,
EMD Millipore: SCC065
From Dr. William Claycomb No mycoplasma contamination
Cell line
(H. sapiens)
HepG2 ATCC HB-8065 STR profiling, no mycoplasma
contamination
Transfected construct
(H. sapiens)
Corin plasmid PMID: 14559895
Transfected construct
(H. sapiens)
sCorin plasmid This paper
Transfected construct
(H. sapiens)
CorinEK plasmid This paper
Transfected construct
(H. sapiens)
EK plasmid This paper
Transfected construct
(H. sapiens)
PT plasmid This paper
Antibody Anti-V5 Thermo Fisher R96025
Antibody Anti-V5-HRP Thermo Fisher R96125
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Antibody Anti-GAPDH EMD Millipore MAB374
Antibody Anti-PDI Abcam ab3672 Immunostaining
Antibody Anti-TGN46 Abcam ab50595
Antibody Anti-Igg (mouse)-Alexa-594 Thermo Fisher A-21203
Antibody Anti-Igg (rabbit)-Alexa-488 Thermo Fisher A-11008
Antibody Anti-calnexin (human) Cell Signaling 2679T
Antibody Anti-BiP Cell Signaling 3177T
Antibody Anti-calreticulin Cell Signaling 12238S
Antibody Anti-HSP70 Cell Signaling 4872T
Antibody Anti-HSP90 Cell Signaling 4877T
Antibody Anti-PDI Cell Signaling 3501T Western blotting
Antibody Anti-Igg (mouse)-HRP KPL 474–1806
Antibody Anti-Igg (rabbit)-HRP KPL 474–1516
Antibody Anti-calnexin (mouse) Abcam ab75125
Antibody Anti-corin (mouse) Homemade PMID: 26259032
Recombinant DNA
reagent
pSecTag/FRT/V5-His
Expression kit (vector)
Thermo Fisher K602501
Recombinant DNA
reagent
pcDNA 3.1/V5-His
Expression kit (vector)
Thermo Fisher K480001
Commercial assay
or kit
ELISA kit (prothrombin) Abcam ab108909
Chemical compound,
drug
1-deoxynojirimycin, DNJ Alfa Aesar J62602-MC
Plasmid constructs
The plasmids expressing corin WT and the mutants N1022Q and R801A were described
(Knappe et al., 2003; Wang et al., 2015). Human corin, EK and prothrombin cDNAs were amplified
and inserted into pSecTag/FRT/V5-His or pcDNA 3.1/V5-His plasmids (Thermo Fisher)
(Supplementary file 3) encoding a C-terminal V5 tag. Additional plasmids expressing mutant corin,
EK and prothrombin were made by QuikChange II Site-Directed Mutagenesis Kit (Agilent
Technologies).
Cell transfection
HEK293 cells (ATCC, CRL-1573, authenticated by STR DNA profiling, no mycoplasma contamination)
were grown in DMEM with 10% fetal bovine serum at 37˚C in humidified incubators. At 70–80% of
confluency, the cells in six-well plates were transfected with the plasmids using Fugene reagents
(Promega). To make stable cells expressing recombinant proteins, the transfected cells were cul-
tured with G418 (400 mg/mL, Teknova). After ~2 w, G418-resistant cells were selected and analyzed
by western blotting.
Western blotting
Recombinant proteins on the cell surface or in the conditioned media and lysates from the trans-
fected cells were immunoprecipitated with an anti-V5 antibody (Thermo Fisher, R96025) and protein
A-Sepharose (Thermo Fisher) for western blotting, as described previously (Wang et al., 2015). Anti-
bodies used were against V5 (Thermo Fisher, R96125), BiP (Cell Signaling, 3177T), calnexin (Cell Sig-
naling, 2679T), calreticulin (Cell Signaling, 12238S), HSP70 (Cell Signaling, 4872T), HSP90 (Cell
Signaling, 4877T) and PDI (Cell Signaling, 3501T). Horseradish peroxidase-labeled secondary anti-
bodies were used (KPL, 474–1806; 474–1516). As a protein loading control for cell lysates, western
blots were re-probed with an anti-GAPDH antibody (EMD Millipore, MAB374). As loading controls
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for cell surface proteins or proteins from conditioned media, eluted biotin-labeled cell surface pro-
teins or total proteins in the conditioned medium were separated by SDS-PAGE followed with Coo-
massie Blue staining. Levels of prominent non-specific bands were used to assess similar protein
amounts in each sample.
CHX-based protein chase assay
HEK293 cells expressing corin WT or the N1022Q mutant in six-well plates were incubated with or
without CHX (Sigma; 100 mg/mL). The cells were lysed at different time points for western blotting,
as described above.
Endo H digestion
Glycosidase Endo H was used to analyze N-glycans on corin in HEK293 cells. The cell lysates were
incubated with Endo H (500 U, New England BioLabs) in 50 mM sodium acetate at 37˚C for 1–2 hr.
The Endo H-treated proteins were analyzed by Western blotting.
Immunostaining
HEK293 cells expressing corin were treated with CHX for 4 hr, fixed with 3% paraformaldehyde, per-
meabilized with 0.2% Triton X-100, and imminostained with antibodies against V5 (1:1000), PDI
(1:200, Abcam, ab3672) or TGN46 (1:200, Abcam, ab50595) and Alexa Fluor-594 or 488-labeled sec-
ondary antibody (1:1000, Thermo Fisher, A-21203; A-11008). In controls, the primary antibody was
replaced by mouse (Thermo Fisher, MA110419) or rabbit (Sigma, I5006) IgG. The stained cells were
examined under a confocal microscope (Leica DM2500) and images were analyzed by ImageJ
software.
Protein cross-linking and proteomic analysis
HEK293 cells expressing corin were incubated with dithiobis succinimidyl propionate (DSP) (0.8 mg/
mL; Thermo Fisher) at 4˚C for 30 min. The reaction was stopped with 0.2 M glycine. Cell lysates
were analyzed by immunoprecipitation and SDS-PAGE. Proteins on silver-stained gels were analyzed
by liquid chromatography-mass spectrum at the Cleveland Clinic Proteomics Core to identify pro-
teins interacting differentially with corin WT and the N1022Q mutant.
Glucosidase inhibition
Murine HL-1 cardiomyocytes were a generous gift from Dr. William Claycomb (Louisiana State Uni-
versity Medical Center, New Orleans; no established authentication method for this murine cell line,
no mycoplasma contamination), as described previously (Wang et al., 2008). Human HepG2 cells
were from ATCC (HB-8065, authenticated by STR DNA profiling, no mycoplasma contamination).
HL-1, HepG2 and HEK293 cells expressing corin were incubated with 1-deoxynojirimycin (DNJ) (2
mM, Alfa Aesar), which inhibits glucosidases, at 37˚C for 24–48 hr. Corin proteins in HL-1 and trans-
fected HEK293 cells were analyzed by western blotting using an antibody against mouse and human
endogenous corin (Chen et al., 2015). Prothrombin expression in HepG2 cell lysates and the condi-
tioned medium was analyzed by ELISA (Abcam, ab108909).
Trypsin digestion
To digest cell surface proteins, HEK293 cells expressing corin or EK were incubated with trypsin
(0.05%, AMRESCO) at 37˚C for 10 min. After washing, cell lysates were prepared for western
blotting.
Effects of calnexin knockdown
To examine effects of calnexin knockdown on corin expression in HL-1 and prothrombin expression
in HepG2 cells, siRNAs targeting murine and human calnexin genes (Origene, SR417891 and
SR300576) and corresponding scrambled control siRNAs (Origene) were transfected using Lipofect-
amine reagents (Thermo Fisher). After 24–48 hr, the cells were collected. Calnexin, corin and pro-
thrombin proteins were analyzed, as described above.
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Statistical analysis
The sample size estimation was based on previous studies and pilot experiments. The Student’s t
test was used to compare two groups with Prism (Graphpad). ANOVA followed by Tukey’s post hoc
analysis was used to compare three or more groups. A p-value of < 0.05 was considered to be statis-
tically significant.
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